Comparative Pharmacology
Head-to-head clinical analysis: CYCLOCORT versus DERMABET.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CYCLOCORT versus DERMABET.
CYCLOCORT vs DERMABET
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Topical corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive actions. Suppresses cytokine production, inhibits phospholipase A2, and reduces prostaglandin synthesis.
Betamethasone dipropionate is a corticosteroid that diffuses across cell membranes and binds to glucocorticoid receptors, forming a complex that translocates to the nucleus and modulates gene transcription. It induces phospholipase A2 inhibitory proteins (lipocortins), thereby inhibiting the release of arachidonic acid and decreasing the synthesis of prostaglandins and leukotrienes. This results in anti-inflammatory, antipruritic, and vasoconstrictive effects.
Apply a thin film topically to affected area twice daily (morning and evening). Not for ophthalmic use.
Apply a thin layer to affected area once or twice daily. Maximum 50 g per week.
None Documented
None Documented
3.5 hours (terminal); clinical effect duration longer due to tissue binding.
Terminal elimination half-life: 3-4 hours; prolonged in hepatic impairment
Primarily hepatic metabolism; inactive metabolites excreted renally (<1% unchanged) and in feces (biliary).
Renal (60-70% as unchanged drug and metabolites), biliary/fecal (30-40%)
Category C
Category C
Topical Corticosteroid
Topical Corticosteroid